General MedicationsTOPICALGeneric
GENTAMICIN SULFATE
GENTAMICIN SULFATE
Standard Dose
EQ 0.1% BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview GENTAMICIN SULFATE is listed in Drugs@FDA under application 209233 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient GENTAMICIN SULFATE Form and strength OINTMENT;TOPICAL - EQ 0.1% BASE Sponsor ENCUBE Submission history Latest submission status date: 2018-12-31 00:00:00.
Structured Monograph
Clinical summary
Approval overview GENTAMICIN SULFATE is listed in Drugs@FDA under application 209233 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient GENTAMICIN SULFATE Form and strength OINTMENT;TOPICAL - EQ 0.1% BASE Sponsor ENCUBE Submission history Latest submission status date: 2018-12-31 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.